BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17110393)

  • 1. Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland.
    Woodford N; Reddy S; Fagan EJ; Hill RL; Hopkins KL; Kaufmann ME; Kistler J; Palepou MF; Pike R; Ward ME; Cheesbrough J; Livermore DM
    J Antimicrob Chemother; 2007 Jan; 59(1):102-5. PubMed ID: 17110393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
    Woodford N; Ward ME; Kaufmann ME; Turton J; Fagan EJ; James D; Johnson AP; Pike R; Warner M; Cheasty T; Pearson A; Harry S; Leach JB; Loughrey A; Lowes JA; Warren RE; Livermore DM
    J Antimicrob Chemother; 2004 Oct; 54(4):735-43. PubMed ID: 15347638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S; Altanlar N
    Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea.
    Lee K; Lee M; Shin JH; Lee MH; Kang SH; Park AJ; Yong D; Chong Y
    Microb Drug Resist; 2006; 12(1):44-9. PubMed ID: 16584308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory.
    Woodford N; Dallow JW; Hill RL; Palepou MF; Pike R; Ward ME; Warner M; Livermore DM
    Int J Antimicrob Agents; 2007 Apr; 29(4):456-9. PubMed ID: 17293088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of plasmid-mediated AmpC beta-lactamase production in Escherichia coli and Klebsiella spp. isolates].
    Balıkçı H; Açıkgöz ZC; Güvenman S; Celikbilek N; Ozdem B
    Mikrobiyol Bul; 2014 Jan; 48(1):82-93. PubMed ID: 24506718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria.
    Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
    Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates.
    Manageiro V; Ferreira E; Pinto M; Fonseca F; Ferreira M; Bonnet R; Caniça M
    Ann Clin Microbiol Antimicrob; 2015 Mar; 14():12. PubMed ID: 25885413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
    Alvarez M; Tran JH; Chow N; Jacoby GA
    Antimicrob Agents Chemother; 2004 Feb; 48(2):533-7. PubMed ID: 14742206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns].
    Zhang WL; Liu J; Zhang J; Su GL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):217-24. PubMed ID: 21624232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
    Pitout JD; Hossain A; Hanson ND
    J Clin Microbiol; 2004 Dec; 42(12):5715-21. PubMed ID: 15583304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.